Clinical Trial Update: A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) [Phase 3]

View source ↗

Summary

A Phase 3 trial in children with pulmonary arterial hypertension tests whether macitentan delays disease progression; the study has completed and results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• OPSUMIT (macitentan)

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2025-09-12